Heart disease remains the leading cause of death in the United States, with a person dying every 34 seconds from cardiovascular disease, claiming almost one million American lives every year and accounting for one in every three deaths. For decades, treatment has centered on symptom management and slowing disease progression rather than reversing damage. But the next generation of innovative approaches is challenging the notion that cardiac injury is irreversible, showing that the heart can be repaired, not just supported, by addressing the genetic and molecular drivers of disease itself. This discussion will spotlight the science, novel approaches and new targets driving the next generation of cardiovascular therapies, where the goal is not merely to extend life, but to restore the vitality and resilience of the human heart.